Status:
COMPLETED
Pregabalin Stabilize Cardiovascular Response to Intubation
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Effect of Laryngoscopy and Tracheal Intubation
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to evaluate whether Pregabalin is safe and effective in stabilizing cardiovascular response to laryngoscopy and tracheal intubation of patients under general anesthesia.
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists(ASA) grade I and II scheduled for elective surgery
Exclusion
- patient refusal.
- patients with serious chronic kidney, liver, lungs, or cardiovascular diseases.
- allergy to any of the study medications.
- patients taking sedation or antihypertensive medications.
- suspected difficult intubation or intubation time more than 22s.
- pregnant or breastfeeding women.
- BMI\>30.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03456947
Start Date
January 1 2017
End Date
June 30 2017
Last Update
March 9 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.